Low prostate-specific antigen and no gleason score upgrade despite more extensive cancer during active surveillance predicts insignificant prostate cancer at radical prostatectomy

Urology

Volumn 80, Issue 4, 2012, Pages 883-888

  Han, Jeong S ^a   Toll, Adam D ^a   Amin, Ali ^a   Carter, H Ballentine ^a   Landis, Patricia ^a   Lee, Stephen ^a   Epstein, Jonathan I ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY;

ADULT; AGED; BIOPSY; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; POPULATION SURVEILLANCE; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 84866738558     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2012.05.045     Document Type: Article

References (23)

1. P.A. Ganz, J.M. Barry, W. Burke National Institutes of Health state-of-the-science conference: role of active surveillance in the management of men with localized prostate cancer Ann Intern Med 156 2012 591 595
2. C. Parker, D. Muston, J. Melia A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival Br J Cancer 94 2006 1361 1368
3. P. Stattin, E. Holmberg, J.E. Johansson Outcomes in localized prostate cancer: national prostate cancer register of Sweden follow-up study J Natl Cancer Inst 102 2010 950 958
4. W.V. Shappley 3rd, S.A. Kenfield, J.L. Kasperzyk Prospective study of determinants and outcomes of deferred treatment or watchful waiting among men with prostate cancer in a nationwide cohort J Clin Oncol 27 2009 4980 4985
5. S.E. Eggener, P.T. Scardino, P.C. Walsh Predicting 15-year prostate cancer specific mortality after radical prostatectomy J Urol 185 2011 869 875
6. T.J. Wilt, M.K. Brawer, M.J. Barry The prostate cancer intervention versus observation trial:VA/NCI/AHRQ cooperative studies program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer Contemp Clin Trials 30 2009 81 87
7. Mohler JL. The 2010 NCCN clinical practice guidelines in oncology on prostate cancer. J Natl Compr Cancer Netw. 8:145.
8. H.B. Carter, P.C. Walsh, P. Landis Expectant management of nonpalpable prostate cancer with curative intent: preliminary results J Urol 167 2002 1231 1234
9. A.S. Duffield, T.K. Lee, H. Miyamoto Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails J Urol 182 2009 2274 2278
10. G. Ploussard, J.I. Epstein, R. Montironi The contemporary concept of significant versus insignificant prostate cancer Eur Urol 60 2011 291 303
11. T. Graif, S. Loeb, K.A. Roehl Under diagnosis and over diagnosis of prostate cancer J Urol 178 2007 88 92
12. J.A. DiGiuseppe, J. Sauvageot, J.I. Epstein Increasing incidence of minimal residual cancer in radical prostatectomy specimens Am J Surg Pathol 21 1997 174 178
13. H.K. Weir, M.J. Thun, B.F. Hankey Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control J Natl Cancer Inst 95 2003 1276 1299
14. S.M. Falzarano, C. Magi-Galluzzi Prostate cancer staging and grading at radical prostatectomy over time Adv Anat Pathol 18 2011 159 164
15. J.J. Tosoian, B.J. Trock, P. Landis Active surveillance program for prostate cancer: an update of the Johns Hopkins experience J Clin Oncol 29 2011 2185 2190
16. R.C. van den Bergh, H. Vasarainen, H.G. van der Poel Short-term outcomes of the prospective multicentre "prostate cancer research International: active surveillance" study BJU Int 105 2010 956 962
17. M.R. Cooperberg, J.E. Cowan, J.F. Hilton Outcomes of active surveillance for men with intermediate-risk prostate cancer J Clin Oncol 29 2011 228 234
18. M.A. Dall'Era, B.R. Konety Active surveillance for low-risk prostate cancer: selection of patients and predictors of progression Nat Clin Pract Urol 5 2008 277 283
19. P.A. Humphrey Gleason grading and prognostic factors in carcinoma of the prostate Mod Pathol 17 2004 292 306
20. P.C. Albertsen, J.A. Hanley, D.F. Gleason Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer JAMA 280 1998 975 980
21. N.M. Corcoran, C.M. Hovens, M.K. Hong Underestimation of Gleason score at prostate biopsy reflects sampling error in lower volume tumours BJU Int 109 5 2012 660 664
22. J.I. Epstein, P.C. Walsh, M. Carmichael Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer JAMA 271 1994 368 374
23. J. Tosoian, S. Loeb PSA and beyond: the past, present, and future of investigative biomarkers for prostate cancer ScientificWorldJournal 10 2010 1919 1931